Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 94 entries
View as:

Effectiveness and Safety of a Single-Center Clinical Study on a CD25 Monoclonal Antibody-Containing GVHD Prophylaxis Scheme to Reduce the Incidence of Severe Acute GVHD After Umbilical Cord Blood Transplantation for Malignant Hematologic Diseases

Phase: N/A Priority: Normal
NCT ID: NCT06480630 Org: User:
Start: 07/01/24 End: 06/30/27 Due: 06/30/28

Observational, Bivariate Analysis of Clinical Big Data in Patients With Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06480617 Org: User:
Start: 10/31/23 End: 12/31/27 Due: 12/31/28

Clinical Study of Apatinib in the Treatment of Advanced Ovarian Cancer After the Failure of Standard Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT03547375 Org: User:
Start: 06/01/18 End: 06/01/20 Due: 06/01/21

The Safety and Efficacy of RD06-03 CART Cell Injection in Patients With R/R Acute B-lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT06307600 Org: User:
Start: 03/15/24 End: 04/01/27 Due: 04/01/28

ENBD After Endoscopic Sphincterotomy Plus Large-balloon Dilation for Preventing PEP

Phase: N/A Priority: Normal
NCT ID: NCT02830984 Org: User:
Start: 07/31/16 End: 07/31/17 Due: 07/31/18

Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With AML

Phase: N/A Priority: Normal
NCT ID: NCT06105658 Org: User:
Start: 10/31/23 End: 02/01/26 Due: 02/01/27

Effect of Letermovir Prophylaxis on CMV-specific Immune Reconstitution Post UCBT

Phase: N/A Priority: Normal
NCT ID: NCT06441669 Org: User:
Start: 05/01/24 End: 05/20/26 Due: 05/20/27

Construction and Validation of a Diagnostic Model for Predicting Molecular Residual Disease and Recurrence of Cervical Cancer Based on Circulating Tumor HPV

Phase: N/A Priority: Normal
NCT ID: NCT06456112 Org: User:
Start: 07/01/24 End: 07/30/26 Due: 07/30/27

QH103 Cell Injection for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT06056752 Org: User:
Start: 09/27/23 End: 07/03/26 Due: 07/03/27

Apatinib Treating Patients With Advanced Cervical Cancer After Radiotherapy and First-line Chemotherapy.

Phase: N/A Priority: Normal
NCT ID: NCT03546855 Org: User:
Start: 06/01/18 End: 06/01/20 Due: 06/01/21

Clinical Study of Radiotherapy Combined With Donafenib for Neoadjuvant Treatment of Patients With HCC With Portal Vein Carcinoma Thrombosis

Phase: N/A Priority: Normal
NCT ID: NCT05022628 Org: User:
Start: 09/30/21 End: 08/31/24 Due: 08/31/25

Tumor Immunity and Cancer Recurrence Prediction Model

Phase: N/A Priority: Normal
NCT ID: NCT06855290 Org: User:
Start: 06/01/25 End: 12/31/26 Due: 12/31/27

iDAP Injection in the Treatment of Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT06583291 Org: User:
Start: 10/01/24 End: 10/01/28 Due: 10/01/29

A Clinical Study to Evaluate CUD005 Injection in Patients with Liver Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT06671275 Org: User:
Start: 06/21/24 End: 07/31/26 Due: 07/31/27

Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06539091 Org: User:
Start: 10/01/24 End: 10/01/26 Due: 10/01/27

Epinephrine Sprayed on the Papilla for the Prevention of Post-ERCP Pancreatitis

Phase: N/A Priority: Normal
NCT ID: NCT02839356 Org: User:
Start: 07/31/16 End: 12/31/17 Due: 12/31/18

Application of PLDR External Irradiation Combined With Immune Checkpoint Inhibitors in Recurrent Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06232083 Org: User:
Start: 02/01/24 End: 02/01/26 Due: 02/01/27

Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r DLBCL Clinical Research

Phase: N/A Priority: Normal
NCT ID: NCT05715606 Org: User:
Start: 02/10/23 End: 05/15/25 Due: 05/15/26

A Clinical Study of Portal Vein Embolization and Liver Venous Deprivation

Phase: N/A Priority: Normal
NCT ID: NCT05457374 Org: User:
Start: 03/01/22 End: 03/01/25 Due: 03/01/26

Effect of Nutritional Intervention Based on Prediction Model on Adult Umbilical Cord Blood Transplantation Patients

Phase: N/A Priority: Normal
NCT ID: NCT06553274 Org: User:
Start: 08/31/24 End: 12/31/25 Due: 12/31/26

Lusutrombopag Combined With Recombinant Human Thrombopoietin for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Destined to Undergo Elective Invasive Surgery

Phase: N/A Priority: Normal
NCT ID: NCT06673498 Org: User:
Start: 11/10/24 End: 11/30/25 Due: 11/30/26

Romiplostim N01 for Platelet Recovery in Adult Hematologic Malignancies Patients Undergoing UCBT

Phase: N/A Priority: Normal
NCT ID: NCT06693791 Org: User:
Start: 12/01/24 End: 12/01/26 Due: 12/01/27

NK Cells Infusion for Advanced Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT03619954 Org: User:
Start: 07/01/18 End: 07/01/20 Due: 07/01/21

Head-to-head Comparison of [68Ga]Ga-PSMA-D5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT05955677 Org: User:
Start: 07/10/23 End: 12/31/24 Due: 12/31/25

Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT06294678 Org: User:
Start: 03/01/24 End: 08/31/26 Due: 08/31/27